MGH Gordon PET Core

The MGH Gordon PET Core is cGMP/FDA registered PET drug manufacturer that operates at cost to provide investigators with required personnel, equipment and services to design and conduct research studies using positron emission tomography.

Services

Main services include:

  • Synthesis of radiotracers and radiopharmaceuticals
  • PET and SPECT animal and human imaging
  • Experimental design and pharmacokinetic modeling
  • Validation and regulatory submission of compound for human use


Radiopharmaceuticals Available for Human and Animal Use

The Core has synthesized over 20 compounds for clinical evaluation and routine use for neurology, cardiology and oncology. In addition, it has pioneered the use of 18F Tau imaging agents for neurodegenerative diseases such as Alzheimer’s disease and traumatic brain injuries.

F-18
FDG* (tumour metabolism/hypometabolism)
Florbetaben** (amyloid imaging)
Flutemetamol** (amyloid imaging)
Florbetapir** (amyloid imaging)
Fluciclovine** (tumor metabolism/prostate cancer imaging)
Sodium Fluoride** (bone imaging)
FES (estrogen receptor)†
Flortaucipir [T807] (tau protein)†
FPEB (mGlur5)‡
BFPET (myocardial perfusion) †
GE180 (TSPO/PBR)†
FLT (cellular proliferation)†
THK 5351/GE-216 (tau protein)†
FMISO (hypoxia)†
MK-6240 (tau protein) †
GE179 (NMDA receptor)‡

C-11
PiB (amlyoid)†
Altropane (Dopamine transport)‡
Raclopride (D2/D3 receptor imaging) †
Methionine (amino acid uptake)†
CO (gas for labeling red blood cells in vivo) ‡
Rolipram (PDE-4 receptor imaging) ‡
P943 (5-HT1B) ‡
PBR-28 (TSPO/PBR)† (S,S)-[11C]Methylreboxetine (MeNR/MRB)‡ – targets norepinephrine transporter

N-13
Ammonia*
N2 in Saline (lung perfusion imaging) ‡

Ga-68
DOTATATE** (neuroendocrine tumor imaging)

O-15
C15O2 (blood flow imaging) ‡

*FDA approved, MGH PET Center holds FDA marketing authorization
**FDA approved, available through local commercial nuclear pharmacies
†Active IND held by MGH Gordon PET Core
‡Available under Radioactive Drug Research Committee (RDRC) oversight

The MGH Gordon PET Core can validate a radiopharmaceutical for clinical research use. 


User Fees 

Please visit our website for current rates: https://gordon.mgh.harvard.edu/gc/core/


Late Cancellation Policy

A PET study that is cancelled or rescheduled within 48 business hours of the original imaging session may incur a fee up to the cost of the cancelled imaging session. A radiotracer production that is not cancelled 48 business hours prior to the production day may incur a fee up to the cost of the produced dose.

Late cancellations due to an act of God are not subject to the general cancellation policy. Since our facility operates at cost, please notify Nicole DaSilva at NEDASILVA@mgh.harvard.edu as soon as possible to allow us to make other arrangements. 


Overhead Policy

An investigator using a Partners fund is considered an internal user and is subject to the overhead rate applied by his/her institution. The internal user fee is calculated based on the direct costs of providing each service. The external user fee comprises a direct fee negotiated with the PET Core plus an overhead component. The overhead rate set by Mass General Brigham is 44% for external academic users and 59% for external industry users.


Uncompleted Studies

The PET Core commits its best efforts to successfully complete scheduled studies. However, given the very nature of many PET studies that rely on manufacturing of radiopharmaceuticals and in vivo imaging, the Core cannot be held responsible for costs associated with incomplete studies due to equipment failure or circumstances outside of our control. 


Acknowledgement of Federal Funding

Measurement of radioactivity in blood and tissue samples uses state-of-the- art equipment acquired through the support of the NIH shared instrumentation grant S10OD018035. Users of our blood sampling and kinetic modeling services are encouraged to acknowledge the grant in their publications and to report it back to us.

The grant details are:

  • Project Number: S10OD018035
  • Title: Gamma Counter and Continuous Blood Sampler for Quantitative PET Imaging,
  • PIs: Georges El Fakhri, Marc Normandin


Location

MGH Main Campus, Boston, MA: Edwards Basement (cyclotron, radiochemistry, and human and large animal imaging)
MGH Navy Yard Campus, Charlestown, 149 13th Street, Charlestown, MA (small animal imaging)


Major Equipment

  • GE Discovery PET/CT
  • Automated Radiochemical Synthesis systems
  • E.cam (Siemens) SPECT Systems and Planar Gamma Cameras
  • Exact HR+ Large Bore PET Scanner
  • NeuroPET/CT dedicated high sensitivity brain scanner
  • PC4096 Large Bore PET Scanner
  • Siemens PET/CT Scanner
  • Siemens Symbia SPECT/CT
  • VISTA small animal micro PET/CT
  • Tri-modality MicroPET-SPECT-CT
  • Perkin Elmer Wizard2 2480 gamma counter
  • Perkin Elmer Wizard 3860 gamma counter
  • Swisstrace Twilite II continuous blood counter


Contact Information

Pedram Heidari, Interim Co-Director
Email: Heidari.Pedram@mgh.harvard.edu 

Giuliana Arcovio, Interim Co-Director
Email: garcovio@partners.org 

© 2020 Gordon Center for Medical Imaging